NCT07850778Completed
ONS USE IN COLON CANCER
USE OF PRESCRİBED ORAL NUTRİTİONAL SUPPLEMENTS DURİNG ADJUVANT CHEMOTHERAPY İN STAGE III COLON CANCER AND ASSOCİATED FACTORS: A SİNGLE-CENTER RETROSPECTİVE COHORT STUDY
Source: ClinicalTrials.gov · Last updated 30 Sept 2026
Brief summary (registry, in English)
This retrospective observational cohort study examined oral nutritional supplement (ONS) use and associated factors in patients receiving adjuvant mFOLFOX6 chemotherapy after curative surgery for stage III colon cancer. Medical and routine nutrition follow-up records from Osmaniye Training and Research Hospital between January 2021 and January 2026 were reviewed. The study included 362 patients prescribed ONS. The main outcomes were ONS non-initiation or early discontinuation and failure to meet a study-defined consumption criterion among ONS users. Demographic, clinical, nutritional, and psychosocial factors associated with these outcomes were evaluated.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 209 (actual)
- First submitted
- 23 Sept 2026
- Start date
- 1 Jan 2021
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- Osmaniye Korkut Ata University
- Diseases
- Colorectal cancer
- NCT number
- NCT07850778
What you commit to
- Study type: Observational
- Participants enrolled: 209
- From 1 Jan 2021 to the primary completion date, 1 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receipt of chemotherapy regimens other than mFOLFOX6.
- Dysphagia, previous upper gastrointestinal surgery, or food allergy precluding safe ONS use.
- Additional major surgery performed during colectomy.
Other illness
- Active second malignancy.
- Dementia or a history of cerebrovascular disease.
Other
- Pregnancy or postpartum status.
- Receipt of neoadjuvant or palliative treatment.
- Preoperative ONS use.
- ONS usage that could not be assessed from available records.
- Missing follow-up information or analytical data.
Who the study is looking for
- Age 18 years or older.
- Histopathologically confirmed stage III colon adenocarcinoma according to the eighth edition of the AJCC TNM classification.
- Previous curative surgery for colon cancer.
- Receipt of adjuvant mFOLFOX6 chemotherapy.
- Prescription of oral nutritional supplements (ONS) during adjuvant chemotherapy.
- At least three months of clinical and Nutrition Outpatient Clinic follow-up.
- Complete medical and nutritional records for the variables required for analys
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| osmaniye korkut ata üniversitesi KARACAOĞLAN YERLEŞKESİ D blok sağlık bilimleri fakültesi 1. kat oda no:101 Coordinator of this site? Confirm its status | Merkez | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.